Research and Clinical Trials

A Multicenter Study for the Validation of ALS Biomarkers
Brief Description  
The primary objective is to identify factors that contribute to the pathogenesis of amyotrophic lateral sclerosis (ALS). Development of disease biomarkers and diagnostic laboratory tests would facilitate earlier treatment intervention, help monitor treatment efficacy; and, ultimately, lead to the identification of targets that could be used in therapy development. Specific aim 2 is to assess how biomarkers discovered in aim 1 change with disease course. Blood samples will be collected longit
Who may be Eligible  
Male and females over the age of 18 with a diagnosis of ALS.
ALS - Amyotrophic Lateral Sclerosis
IRB Number  
Principal Investigator  
Brooks, Benjamin

For More Information, Contact  Jaime  L, Shue
Phone:  (704) 446-6253  Fax:  (704) 446-1915  
Address:1010 Edgehill Road North Charlotte, NC 28207